US20160281156A1 - Sequencing Device and Method for Operating a Sequencing Device - Google Patents
Sequencing Device and Method for Operating a Sequencing Device Download PDFInfo
- Publication number
- US20160281156A1 US20160281156A1 US15/074,448 US201615074448A US2016281156A1 US 20160281156 A1 US20160281156 A1 US 20160281156A1 US 201615074448 A US201615074448 A US 201615074448A US 2016281156 A1 US2016281156 A1 US 2016281156A1
- Authority
- US
- United States
- Prior art keywords
- gap
- sequencing
- cavity
- pore
- sequencing device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/06—Lysis of microorganisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
- G01N33/48721—Investigating individual macromolecules, e.g. by translocation through nanopores
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/10—Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0627—Sensor or part of a sensor is integrated
- B01L2300/0636—Integrated biosensor, microarrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0864—Configuration of multiple channels and/or chambers in a single devices comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0415—Moving fluids with specific forces or mechanical means specific forces electrical forces, e.g. electrokinetic
- B01L2400/0421—Moving fluids with specific forces or mechanical means specific forces electrical forces, e.g. electrokinetic electrophoretic flow
Definitions
- the disclosure proceeds from a sequencing device or a method according to the following description.
- the subject matter of the present disclosure is also a computer program.
- the decoding of the genetic code is also referred to as DNA sequencing and is frequently used in science, medicine and forensics.
- a comprehensive sample preparation such as lysis and purification, is indispensable for the purposes of sequencing, in order to obtain sufficiently pure nucleic acids for sequencing.
- a sequencing device having at least one sequencing channel which fluidically connects a first gap with a second gap, wherein the sequencing channel is formed as a cavity in the region of the first gap and is formed as a pore in the region of the second gap, wherein the pore has a smaller cross section than the cavity.
- a sequencing device can be understood to mean a device for determining a DNA sequence.
- the DNA sequence can be evaluated by a conventional evaluation unit.
- a gap can be a channel for guiding one medium or for guiding a plurality of media.
- the first gap can be formed by a clearance between a base body of the device and a first planar substrate.
- the second gap can be formed by a clearance between the base body and a second planar substrate.
- the substrates can be arranged on opposite sides of the base body.
- the substrates can be arranged substantially parallel to one another.
- a sequencing channel can break through or open the base body.
- a cavity can be referred to as a (broad) indentation in a base body having a fluidic passage into the (narrow) pore, the pore likewise forming an opening of the base body.
- the cavity can also be referred to as a well.
- the cross section of the pore is (substantially) smaller than the cross section of the cavity, for example smaller than the cross section of the cavity by one order of magnitude.
- a cross section can be understood here to mean a cross-sectional area or a clearance between two opposite edges of the cavity and/or of the pore in the region of the formation of the cross section.
- the cross section can also form a diameter of the sequencing channel when the sequencing channel has a circular base area.
- the pore can have a length which substantially corresponds to a depth of the cavity.
- the exemplary single-molecule sequencer presented here omits a clonal amplification of the DNA molecules or nucleic acids to be sequenced, and, as a result, there is no sequencing bias. Similarly, bridge amplification is not required. In addition, a complicated sample preparation can be dispensed with.
- a microfluidic environment is presented, which environment makes it possible to individually disrupt cells in a sample solution, to purify the DNA and to individually sequence said DNA directly afterwards in downstream pores.
- the system presented here allows a genuine single-cell sequencing process. As a result, it is possible, using a plurality of sequencing channels, to determine the genetic heterogeneity of a sample solution containing cells.
- the system presented here further allows the analysis of very small cell amounts, since each cell can be separately disrupted in one well of the microwell array and sent for nanopore sequencing.
- the system presented here rules out a DNA contamination of the DNA or cells to be sequenced, since the cell lysates are fed into the actual sequencing process in an automated and integrated manner, avoiding DNA carryover and contamination, which could adversely affect the sequencing result.
- the cavity can be designed to accommodate an individual cell.
- the cavity can be small enough to allow precisely one individual cell to fit in. More particularly, the cavity can have a cross section between one micrometer and three hundred micrometers. More particularly, the cavity can have a cross section between three micrometers and 30 micrometers.
- the first gap and, alternatively or additionally, the second gap can have a gap width between two micrometers and one millimeter. More particularly, the first gap and, alternatively or additionally, the second gap can have a gap width between five micrometers and 500 micrometers.
- the gap width can be adjusted depending on the media used for the purposes of sequencing preparation and for the purposes of sequencing itself. More particularly, the gap width can be optimized for a laminar flow within the gaps.
- An electrophoresis path can be arranged in the pore. This makes it possible to directly use the sequencing device presented here for an electrophoresis process.
- the sequencing device can have at least one further sequencing channel More particularly, a multiplicity of sequencing channels can be arranged to form a matrix. More particularly, the matrix can have a density between 1 ⁇ 10 3 and 25 ⁇ 10 6 sequencing channels per square centimeter. By means of many sequencing channels, it is possible to carry out many sequencing processes at the same time.
- a method for operating a microfluidic sequencing device having at least one microfluidic sequencing channel which fluidically connects a first microfluidic gap with a second microfluidic gap, wherein the sequencing channel is formed as a cavity in the region of the first gap and is formed as a pore in the region of the second gap, wherein the pore has a smaller cross section than the cavity, wherein the method comprises the following steps:
- An aqueous solution containing cells can be fed in as sample solution.
- a centrifugation, a sedimentation and, alternatively or additionally, a vacuum treatment can be further carried out in order to introduce the cell into the cavity.
- a chemical lysis, an enzymatic lysis, an electrical lysis, an ultrasonic lysis and, alternatively or additionally, a thermal lysis can, for example, be carried out in order to release the cellular DNA.
- a thermal lysis can, for example, be carried out in order to release the cellular DNA.
- an organic phase i.e. liquid
- the organic phase can be introduced into the first gap by means of a laminar flow.
- the organic phase can have a low solubility in the aqueous solution. Because of the laminar flow, it is possible to avoid turbulences.
- a rinse liquid can be introduced into the first gap. More particularly, the rinse liquid can be introduced into the first gap by means of a laminar flow.
- the rinse liquid can easily remove or displace a lysis liquid.
- the rinse liquid can itself be easily removed from the gap. Because of the laminar flow, it is possible to avoid turbulences.
- an electric voltage can be applied between a first substrate bounding the first gap and a second substrate bounding the second gap in order to sequence the DNA in the pore. Because of a resultant electric field, it is possible to sequence the DNA by means of electrophoresis.
- This method can, for example, be implemented in software or hardware or in a mixed form composed of software and hardware, for example in a control unit.
- the approach presented here further provides a device designed to carry out, control or realize the steps of a variant of a method presented here in corresponding units.
- This embodiment variant of the disclosure in the form of a device can also rapidly and efficiently achieve the object underlying the disclosure.
- a device can be understood here to mean an electrical instrument which processes sensor signals and outputs control and/or data signals depending on said sensor signals.
- the device can have an interface which can be hardware-based and/or software-based.
- the interfaces can, for example, be part of a so-called system ASIC, which includes a very wide variety of different functions of the device.
- the interfaces can be distinct, integrated circuits or to at least partly consist of discrete components.
- the interfaces can be software modules which are, for example, present on a microcontroller in addition to other software modules.
- a computer program product or computer program containing program code which can be stored on a machine-readable carrier or storage medium such as a semiconductor memory, a hard disk storage medium or an optical storage medium and is used to carry out, realize and/or control the steps of the method according to any of the above-described embodiments, especially when the program product or program is executed on a computer or a device.
- FIG. 1 shows a diagram of a sequencing device according to one exemplary embodiment
- FIG. 2 shows a flowchart of a method for operating a sequencing device according to one exemplary embodiment
- FIG. 3 shows a diagram of feeding of a sample solution into a sequencing device according to one exemplary embodiment
- FIG. 4 shows a diagram of lysis of cells in a sequencing device according to one exemplary embodiment
- FIG. 5 shows a diagram of isolated DNA in a sequencing device according to one exemplary embodiment
- FIG. 6 shows a diagram of sequencing of DNA in a sequencing device according to one exemplary embodiment.
- FIG. 1 shows a diagram of a sequencing device 100 according to one exemplary embodiment.
- the sequencing device 100 has a plurality of sequencing channels 102 .
- the diagrammatic plane selected here shows a first sequencing channel 102 a, a second sequencing channel 102 b, a third sequencing channel 102 c, a fourth sequencing channel 102 d, a fifth sequencing channel 102 e and a sixth sequencing channel 102 f next to one another.
- the sequencing channels 102 are similar.
- the sequencing channels 102 are arranged to form a matrix 104 .
- the sequencing channels 102 are formed in a plate-shaped base body 106 .
- Each of the sequencing channels 102 represents a fluidic connection between a first gap 108 on a first side of the base body 106 and a second gap 110 on an opposing second side of the base body 106 .
- the sequencing channel 102 is formed as a cavity 112 in the region of the first gap 108 .
- the sequencing channel 102 is formed as a pore 114 .
- the pore 114 has a (substantially) smaller cross section than the cavity 112 .
- the cavity 112 is designed to accommodate an individual cell to be sequenced.
- the cross section or diameter of the cavity is 100- to 100 000-fold larger than the cross section or diameter of the pore.
- the first gap 108 is formed between the base body 106 and a lid substrate 116 and has a gap width designed to allow a laminar flow in the first gap 108 .
- the second gap 110 is formed here between the base body 106 and a bottom substrate 118 .
- the second gap 110 likewise has a gap width designed to allow a laminar or nonlaminar flow in the second gap 108 .
- the lid substrate 116 has a first electrical connection 120 for electrical contacting of the lid substrate 116 .
- the bottom substrate 118 has a second electrical connection 122 for electrical contacting of the bottom substrate 118 .
- An electric voltage can be applied between the two electrical contacts 120 , 122 in order to generate an electric field between the lid substrate 116 and the bottom substrate 118 .
- a cross section through a microwell nanopore hybrid 100 is shown.
- the microwell array 104 has cavities 112 opened toward the surface of the microwell array 104 .
- the cavities 112 can be referred to as wells 112 .
- Connected to the underside of the wells 112 is a pore 114 or nanopore 114 in each case.
- microfluidic gap 108 Between the microwell surface and a lid substrate 116 , there is a microfluidic gap 108 with dimensions of two to 1000 ⁇ m, preferably five to 500 ⁇ m. Between the underside of the microwell array 104 and the bottom substrate 118 , there is likewise a microfluidic gap 110 with dimensions of two to 1000 ⁇ m, preferably five to 500 ⁇ m. The clearance is selected such that a laminar through-flow is promoted. An electric field can be applied between the lid substrate 116 and the bottom substrate 118 .
- the dimensions of a well 112 can be between 500 nm and 300 ⁇ m, preferably between one ⁇ m and 30 ⁇ m.
- the density of the wells 112 on the microwell array 104 can be between 1 ⁇ 10 3 and 25 ⁇ 10 6 wells 112 per cm 2 .
- the approach presented here can be used for analytical systems, especially for microfluidic lab-on-a-chip systems for environmental analysis or medical diagnostics.
- FIG. 2 shows a flowchart of a method 200 for operating a sequencing device according to one exemplary embodiment.
- the method 200 can be carried out on a sequencing device, as shown in FIG. 1 .
- the sequencing device is connected to a device for operating the sequencing device. More particularly, the sequencing device is designed as a single-use cartridge which is connected via interfaces to the operating device.
- the method 200 has a feeding step 202 , a lysis step 204 , a rinsing step 206 , a filling step 208 and a sequencing step 210 .
- a sample solution is fed into the first gap in order to introduce an individual cell into at least one of the cavities.
- a negative pressure is established in the first gap in order to suck the sample solution into the first gap and thus into the cavities.
- the sample solution can be pressed into the first gap by means of a positive pressure.
- the sample solution can be drawn into the gap as a result of the capillary effect.
- the at least one cell is broken up within its cavity into its cellular constituents in order to release cellular DNA of the cell.
- the lysis can be achieved in different ways. For example, in the lysis step 204 , a chemical lysis, an enzymatic lysis, an electrical lysis, an ultrasonic lysis and, alternatively or additionally, a thermal lysis can be carried out in order to release the cellular DNA.
- the first gap is rinsed in order to remove undesired cellular constituents of the cell from the cavity and, alternatively or additionally, from the first gap and to isolate the DNA in the cavity.
- a rinse fluid can be guided through the first gap, which fluid selectively removes all cellular constituents apart from the DNA from the cavity.
- the first gap and the second gap are filled with a sequencing buffer.
- the sequencing buffer can be sucked or drawn and/or pressed into the gap.
- the DNA is sequenced in the pore.
- a centrifugation, a sedimentation and, alternatively or additionally, a vacuum treatment can be further carried out in order to introduce the cell into the cavity.
- FIG. 3 shows a diagram of feeding of a sample solution 300 into a sequencing device 100 according to one exemplary embodiment.
- the sequencing device 100 substantially corresponds to the sequencing device in FIG. 1 .
- Feeding represents one step of a method for operating the sequencing device, as described in FIG. 2 .
- an aqueous solution 300 containing cells 302 is fed into the first gap 108 . While this is done, the cavities 112 are likewise wetted with the aqueous solution 300 .
- the cells 302 are introduced into the cavities 112 by means of a centrifugation, a sedimentation and, alternatively or additionally, a vacuum treatment. During this action, only one cell 302 fits into each cavity 112 . As a result, the individual cells 302 are isolated from one another.
- a miniaturized phenol/chloroform extraction is used.
- the cells 302 to be analyzed in water or a sample solution 300 containing cells 302 are introduced into the chip 100 .
- FIG. 4 shows a diagram of lysis of cells 302 in a sequencing device 100 according to one exemplary embodiment.
- the sequencing device 100 substantially corresponds to the sequencing device in FIG. 1 .
- Lysis represents one step of a method for operating the sequencing device, as described in FIG. 2 .
- the first gap 108 is filled with a lysis liquid 400 .
- the lysis liquid 400 brings about a lysis of the cells 302 , involving the cells being broken up into their cellular constituents.
- the cells can be electrically lysed by application of an electric field between 120 and 122 .
- the lysis liquid 400 for example penetrates the cavities 112 only insignificantly because of its surface tension. A remainder of the aqueous solution 300 remains in each of the cavities 112 .
- the microfluidic gap 108 is filled with an organic phase 400 , in this case phenol in a 1:1 ratio.
- the DNA, cellular fragments and cellular contents present in the aqueous solution 300 are separated owing to their different solubilities.
- the DNA remains in the aqueous phase 300 ; all the other constituents pass over into the organic phase 400 by diffusion.
- Said constituents are removed from the chip 100 by subsequent rinsing out of the organic phase 400 , for example using chloroform and isoamyl alcohol, for example in a 24:1 ratio.
- FIGS. 3 and 4 show figures in the form of intermediate stages in a sample preparation procedure for a nanopore sequencing process according to the approach presented here.
- a sample solution containing cells is fed into the microfluidic gap in FIG. 3 .
- the cells are introduced into the wells by means of centrifugation, sedimentation or with the aid of vacuum. Thereafter, the cells are lysed in FIG. 4 .
- known methods can be used, such as a chemical lysis, an enzymatic lysis, an electrical lysis, an ultrasonic lysis and/or a thermal lysis.
- FIG. 5 shows a diagram of isolated DNA 500 in a sequencing device 100 according to one exemplary embodiment.
- the sequencing device 100 substantially corresponds to the sequencing device in FIG. 1 .
- the lysis liquid or a rinse liquid subsequently introduced into the first gap 108 has been removed from the first gap 108 .
- the remainder of the aqueous solution 300 containing the DNA 500 is arranged in each cavity 112 .
- the chip 100 after purification.
- the cellular DNA 500 is present isolated in an aqueous phase 300 in the various wells 112 .
- FIG. 6 shows a diagram of sequencing of DNA 500 in a sequencing device 100 according to one exemplary embodiment.
- the sequencing device 100 substantially corresponds to the sequencing device in FIG. 1 .
- Sequencing represents one step of a method for operating the sequencing device, as described in FIG. 2 .
- a sequencing medium 600 is introduced into the first gap 108 and the second gap 110 .
- the pores 114 are likewise filled with the sequencing medium 600 .
- the aqueous solution 300 is initially arranged in the cavities 112 .
- the aqueous solution mixes with the sequencing medium by means of diffusion.
- the cavities are filled with the sequencing medium (the aqueous solution is diluted out).
- a DC voltage source 602 is activated between the electrical connections 120 , 122 . This forms an electric field between the lid substrate 116 and the bottom substrate 118 .
- the electric field pulls the DNA through the pores 114 , and a migration rate of the DNA 500 or fragments of the DNA 500 in the sequencing medium 600 can be evaluated.
- the microfluidic gaps 108 , 110 are filled with a sequencing buffer 600 .
- the pores 114 have an electrophoresis path, for example the same buffer 600 with which the gaps 108 , 110 are also filled or an agarose gel.
- the detection of the fragment length of the DNA 500 and/or the detection of specific bases can be achieved using known methods.
- the detection can be achieved by electrical, electrochemical or optical means.
- Different buffers 600 can be used depending on the detection method.
- 1 M KCl salt solution containing 10 mM Tris-HCl and 1 mM EDTA (ethylenediaminetetraacetic acid), pH 8.0 at room temperature or 3 M KCl solution, pH 10.4, containing 1 mM EDTA for the electrical detection using a solid-state nanopore.
- an exemplary embodiment comprises an “and/or” link between a first feature and a second feature, this is to be read as meaning that the exemplary embodiment has, according to one embodiment, both the first feature and the second feature and, according to a further embodiment, either only the first feature or only the second feature.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Nanotechnology (AREA)
- Pathology (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Clinical Laboratory Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Dispersion Chemistry (AREA)
Abstract
A sequencing device has at least one sequencing channel configured to fluidically connect a first gap with a second gap. The sequencing channel is formed as a cavity in the region of the first gap and is formed as a pore in the region of the second gap. The pore has a smaller cross section than the cavity.
Description
- This application claims priority under 35 U.S.C. §119 to patent application number DE 10 2015 205 435.7, filed on Mar. 25, 2015 in Germany, the disclosure of which is incorporated herein by reference in its entirety.
- The disclosure proceeds from a sequencing device or a method according to the following description. The subject matter of the present disclosure is also a computer program.
- The decoding of the genetic code is also referred to as DNA sequencing and is frequently used in science, medicine and forensics. Up to now, a comprehensive sample preparation, such as lysis and purification, is indispensable for the purposes of sequencing, in order to obtain sufficiently pure nucleic acids for sequencing.
- Against this background, the approach introduced here presents a sequencing device and additionally a method for operating a sequencing device, a device for controlling such a method and lastly a corresponding computer program according to the following description. Advantageous developments and improvements of the device specified in the following description are possible by means of the measures listed in the following description.
- There is presented a sequencing device having at least one sequencing channel which fluidically connects a first gap with a second gap, wherein the sequencing channel is formed as a cavity in the region of the first gap and is formed as a pore in the region of the second gap, wherein the pore has a smaller cross section than the cavity.
- A sequencing device can be understood to mean a device for determining a DNA sequence. The DNA sequence can be evaluated by a conventional evaluation unit. A gap can be a channel for guiding one medium or for guiding a plurality of media. In particular, the first gap can be formed by a clearance between a base body of the device and a first planar substrate. The second gap can be formed by a clearance between the base body and a second planar substrate. In this connection, the substrates can be arranged on opposite sides of the base body. The substrates can be arranged substantially parallel to one another. A sequencing channel can break through or open the base body. A cavity can be referred to as a (broad) indentation in a base body having a fluidic passage into the (narrow) pore, the pore likewise forming an opening of the base body. The cavity can also be referred to as a well. The cross section of the pore is (substantially) smaller than the cross section of the cavity, for example smaller than the cross section of the cavity by one order of magnitude. A cross section can be understood here to mean a cross-sectional area or a clearance between two opposite edges of the cavity and/or of the pore in the region of the formation of the cross section. The cross section can also form a diameter of the sequencing channel when the sequencing channel has a circular base area. At the same time, the pore can have a length which substantially corresponds to a depth of the cavity.
- The exemplary single-molecule sequencer presented here omits a clonal amplification of the DNA molecules or nucleic acids to be sequenced, and, as a result, there is no sequencing bias. Similarly, bridge amplification is not required. In addition, a complicated sample preparation can be dispensed with.
- A microfluidic environment is presented, which environment makes it possible to individually disrupt cells in a sample solution, to purify the DNA and to individually sequence said DNA directly afterwards in downstream pores.
- The system presented here allows a genuine single-cell sequencing process. As a result, it is possible, using a plurality of sequencing channels, to determine the genetic heterogeneity of a sample solution containing cells.
- There is a high sensitivity of the entire system, since purification, for example by means of a column, involving high losses during purification in the case of small DNA concentrations is omitted.
- The system presented here further allows the analysis of very small cell amounts, since each cell can be separately disrupted in one well of the microwell array and sent for nanopore sequencing.
- There is no longer a need for a separate sample purification for a sequencing process; all the individual steps or individual methods can be represented and carried out in a single microfluidic environment. This lowers the error rate of the entire system and the time invested.
- The system presented here rules out a DNA contamination of the DNA or cells to be sequenced, since the cell lysates are fed into the actual sequencing process in an automated and integrated manner, avoiding DNA carryover and contamination, which could adversely affect the sequencing result.
- To this end, the cavity can be designed to accommodate an individual cell. To this end, the cavity can be small enough to allow precisely one individual cell to fit in. More particularly, the cavity can have a cross section between one micrometer and three hundred micrometers. More particularly, the cavity can have a cross section between three micrometers and 30 micrometers.
- The first gap and, alternatively or additionally, the second gap can have a gap width between two micrometers and one millimeter. More particularly, the first gap and, alternatively or additionally, the second gap can have a gap width between five micrometers and 500 micrometers. The gap width can be adjusted depending on the media used for the purposes of sequencing preparation and for the purposes of sequencing itself. More particularly, the gap width can be optimized for a laminar flow within the gaps.
- An electrophoresis path can be arranged in the pore. This makes it possible to directly use the sequencing device presented here for an electrophoresis process.
- The sequencing device can have at least one further sequencing channel More particularly, a multiplicity of sequencing channels can be arranged to form a matrix. More particularly, the matrix can have a density between 1×103 and 25×106 sequencing channels per square centimeter. By means of many sequencing channels, it is possible to carry out many sequencing processes at the same time.
- Furthermore, there is presented a method for operating a microfluidic sequencing device having at least one microfluidic sequencing channel which fluidically connects a first microfluidic gap with a second microfluidic gap, wherein the sequencing channel is formed as a cavity in the region of the first gap and is formed as a pore in the region of the second gap, wherein the pore has a smaller cross section than the cavity, wherein the method comprises the following steps:
- feeding a sample solution into the first gap in order to introduce a cell into the cavity;
- lysing the cell into its cellular constituents in order to release cellular DNA of the cell;
- rinsing the first gap in order to remove undesired cellular constituents of the cell from the cavity and/or the first gap and to isolate the DNA in the cavity;
- filling the first gap and the second gap with a sequencing buffer; and
- sequencing the DNA in the pore.
- An aqueous solution containing cells can be fed in as sample solution.
- In the feeding step, a centrifugation, a sedimentation and, alternatively or additionally, a vacuum treatment can be further carried out in order to introduce the cell into the cavity. As a result, it is possible to sequence the individual cells at specific sites and to speed up the sequencing process.
- In the lysis step, a chemical lysis, an enzymatic lysis, an electrical lysis, an ultrasonic lysis and, alternatively or additionally, a thermal lysis can, for example, be carried out in order to release the cellular DNA. In the sequencing device presented here, it is possible to carry out and/or combine different lysis methods. This means that different cells can be lysed.
- In the lysis step, an organic phase (i.e. liquid) can be introduced into the first gap. More particularly, the organic phase can be introduced into the first gap by means of a laminar flow. The organic phase can have a low solubility in the aqueous solution. Because of the laminar flow, it is possible to avoid turbulences.
- In the rinsing step, a rinse liquid can be introduced into the first gap. More particularly, the rinse liquid can be introduced into the first gap by means of a laminar flow. The rinse liquid can easily remove or displace a lysis liquid. The rinse liquid can itself be easily removed from the gap. Because of the laminar flow, it is possible to avoid turbulences.
- In the sequencing step, an electric voltage can be applied between a first substrate bounding the first gap and a second substrate bounding the second gap in order to sequence the DNA in the pore. Because of a resultant electric field, it is possible to sequence the DNA by means of electrophoresis.
- This method can, for example, be implemented in software or hardware or in a mixed form composed of software and hardware, for example in a control unit.
- The approach presented here further provides a device designed to carry out, control or realize the steps of a variant of a method presented here in corresponding units. This embodiment variant of the disclosure in the form of a device can also rapidly and efficiently achieve the object underlying the disclosure.
- A device can be understood here to mean an electrical instrument which processes sensor signals and outputs control and/or data signals depending on said sensor signals. The device can have an interface which can be hardware-based and/or software-based. In the case of a hardware-based design, the interfaces can, for example, be part of a so-called system ASIC, which includes a very wide variety of different functions of the device. However, it is also possible for the interfaces to be distinct, integrated circuits or to at least partly consist of discrete components. In the case of a software-based design, the interfaces can be software modules which are, for example, present on a microcontroller in addition to other software modules.
- Also of advantage is a computer program product or computer program containing program code which can be stored on a machine-readable carrier or storage medium such as a semiconductor memory, a hard disk storage medium or an optical storage medium and is used to carry out, realize and/or control the steps of the method according to any of the above-described embodiments, especially when the program product or program is executed on a computer or a device.
- Exemplary embodiments of the disclosure are depicted in the drawings and elucidated in detail in the following description.
-
FIG. 1 shows a diagram of a sequencing device according to one exemplary embodiment; -
FIG. 2 shows a flowchart of a method for operating a sequencing device according to one exemplary embodiment; -
FIG. 3 shows a diagram of feeding of a sample solution into a sequencing device according to one exemplary embodiment; -
FIG. 4 shows a diagram of lysis of cells in a sequencing device according to one exemplary embodiment; -
FIG. 5 shows a diagram of isolated DNA in a sequencing device according to one exemplary embodiment; and -
FIG. 6 shows a diagram of sequencing of DNA in a sequencing device according to one exemplary embodiment. - In the following description of favorable exemplary embodiments of the present disclosure, identical or similar reference signs are used for the elements which are shown in the various figures and act in a similar manner, with a repeated description of said elements being dispensed with.
-
FIG. 1 shows a diagram of asequencing device 100 according to one exemplary embodiment. Thesequencing device 100 has a plurality of sequencing channels 102. The diagrammatic plane selected here shows afirst sequencing channel 102 a, asecond sequencing channel 102 b, athird sequencing channel 102 c, afourth sequencing channel 102 d, afifth sequencing channel 102 e and asixth sequencing channel 102 f next to one another. The sequencing channels 102 are similar. The sequencing channels 102 are arranged to form amatrix 104. The sequencing channels 102 are formed in a plate-shapedbase body 106. Each of the sequencing channels 102 represents a fluidic connection between afirst gap 108 on a first side of thebase body 106 and asecond gap 110 on an opposing second side of thebase body 106. - The sequencing channel 102 is formed as a
cavity 112 in the region of thefirst gap 108. In the region of thesecond gap 110, the sequencing channel 102 is formed as apore 114. In this connection, thepore 114 has a (substantially) smaller cross section than thecavity 112. More particularly, thecavity 112 is designed to accommodate an individual cell to be sequenced. For example, the cross section or diameter of the cavity is 100- to 100 000-fold larger than the cross section or diameter of the pore. - In the exemplary embodiment shown, the
first gap 108 is formed between thebase body 106 and alid substrate 116 and has a gap width designed to allow a laminar flow in thefirst gap 108. - The
second gap 110 is formed here between thebase body 106 and abottom substrate 118. Thesecond gap 110 likewise has a gap width designed to allow a laminar or nonlaminar flow in thesecond gap 108. - The
lid substrate 116 has a firstelectrical connection 120 for electrical contacting of thelid substrate 116. - The
bottom substrate 118 has a secondelectrical connection 122 for electrical contacting of thebottom substrate 118. - An electric voltage can be applied between the two
electrical contacts lid substrate 116 and thebottom substrate 118. - A cross section through a
microwell nanopore hybrid 100 is shown. Themicrowell array 104 hascavities 112 opened toward the surface of themicrowell array 104. Thecavities 112 can be referred to aswells 112. Connected to the underside of thewells 112 is apore 114 ornanopore 114 in each case. - Between the microwell surface and a
lid substrate 116, there is amicrofluidic gap 108 with dimensions of two to 1000 μm, preferably five to 500 μm. Between the underside of themicrowell array 104 and thebottom substrate 118, there is likewise amicrofluidic gap 110 with dimensions of two to 1000 μm, preferably five to 500 μm. The clearance is selected such that a laminar through-flow is promoted. An electric field can be applied between thelid substrate 116 and thebottom substrate 118. - In the
microwell array 104 presented here, the dimensions of a well 112 can be between 500 nm and 300 μm, preferably between one μm and 30 μm. The density of thewells 112 on themicrowell array 104 can be between 1×103 and 25×106wells 112 per cm2. - The approach presented here can be used for analytical systems, especially for microfluidic lab-on-a-chip systems for environmental analysis or medical diagnostics.
-
FIG. 2 shows a flowchart of amethod 200 for operating a sequencing device according to one exemplary embodiment. Themethod 200 can be carried out on a sequencing device, as shown inFIG. 1 . To this end, the sequencing device is connected to a device for operating the sequencing device. More particularly, the sequencing device is designed as a single-use cartridge which is connected via interfaces to the operating device. - The
method 200 has afeeding step 202, alysis step 204, a rinsingstep 206, a fillingstep 208 and asequencing step 210. In thefeeding step 202, a sample solution is fed into the first gap in order to introduce an individual cell into at least one of the cavities. For example, for the purposes of feeding, a negative pressure is established in the first gap in order to suck the sample solution into the first gap and thus into the cavities. Similarly, the sample solution can be pressed into the first gap by means of a positive pressure. Alternatively, the sample solution can be drawn into the gap as a result of the capillary effect. In thelysis step 204, the at least one cell is broken up within its cavity into its cellular constituents in order to release cellular DNA of the cell. The lysis can be achieved in different ways. For example, in thelysis step 204, a chemical lysis, an enzymatic lysis, an electrical lysis, an ultrasonic lysis and, alternatively or additionally, a thermal lysis can be carried out in order to release the cellular DNA. In the rinsingstep 206, the first gap is rinsed in order to remove undesired cellular constituents of the cell from the cavity and, alternatively or additionally, from the first gap and to isolate the DNA in the cavity. More particularly, a rinse fluid can be guided through the first gap, which fluid selectively removes all cellular constituents apart from the DNA from the cavity. In the fillingstep 208, the first gap and the second gap are filled with a sequencing buffer. As in thefeeding step 202, the sequencing buffer can be sucked or drawn and/or pressed into the gap. In thesequencing step 210, the DNA is sequenced in the pore. - In
step 202, a centrifugation, a sedimentation and, alternatively or additionally, a vacuum treatment can be further carried out in order to introduce the cell into the cavity. -
FIG. 3 shows a diagram of feeding of asample solution 300 into asequencing device 100 according to one exemplary embodiment. In this case, thesequencing device 100 substantially corresponds to the sequencing device inFIG. 1 . Feeding represents one step of a method for operating the sequencing device, as described inFIG. 2 . - Here, an
aqueous solution 300 containingcells 302 is fed into thefirst gap 108. While this is done, thecavities 112 are likewise wetted with theaqueous solution 300. Thecells 302 are introduced into thecavities 112 by means of a centrifugation, a sedimentation and, alternatively or additionally, a vacuum treatment. During this action, only onecell 302 fits into eachcavity 112. As a result, theindividual cells 302 are isolated from one another. - What is shown is an exemplary embodiment for a purification of the cellular DNA. In this case, a miniaturized phenol/chloroform extraction is used. To this end, the
cells 302 to be analyzed in water or asample solution 300 containingcells 302 are introduced into thechip 100. -
FIG. 4 shows a diagram of lysis ofcells 302 in asequencing device 100 according to one exemplary embodiment. In this case, thesequencing device 100 substantially corresponds to the sequencing device inFIG. 1 . Lysis represents one step of a method for operating the sequencing device, as described inFIG. 2 . - In said step, the
first gap 108 is filled with alysis liquid 400. Thelysis liquid 400 brings about a lysis of thecells 302, involving the cells being broken up into their cellular constituents. Alternatively, the cells can be electrically lysed by application of an electric field between 120 and 122. Thelysis liquid 400 for example penetrates thecavities 112 only insignificantly because of its surface tension. A remainder of theaqueous solution 300 remains in each of thecavities 112. - Following the introduction, the
microfluidic gap 108 is filled with anorganic phase 400, in this case phenol in a 1:1 ratio. The DNA, cellular fragments and cellular contents present in theaqueous solution 300 are separated owing to their different solubilities. The DNA remains in theaqueous phase 300; all the other constituents pass over into theorganic phase 400 by diffusion. Said constituents are removed from thechip 100 by subsequent rinsing out of theorganic phase 400, for example using chloroform and isoamyl alcohol, for example in a 24:1 ratio. - In other words,
FIGS. 3 and 4 show figures in the form of intermediate stages in a sample preparation procedure for a nanopore sequencing process according to the approach presented here. - For the purposes of sample preparation, a sample solution containing cells is fed into the microfluidic gap in
FIG. 3 . The cells are introduced into the wells by means of centrifugation, sedimentation or with the aid of vacuum. Thereafter, the cells are lysed inFIG. 4 . To this end, known methods can be used, such as a chemical lysis, an enzymatic lysis, an electrical lysis, an ultrasonic lysis and/or a thermal lysis. -
FIG. 5 shows a diagram ofisolated DNA 500 in asequencing device 100 according to one exemplary embodiment. In this case, thesequencing device 100 substantially corresponds to the sequencing device inFIG. 1 . Here, the lysis liquid or a rinse liquid subsequently introduced into thefirst gap 108, fromFIG. 4 , has been removed from thefirst gap 108. The remainder of theaqueous solution 300 containing theDNA 500 is arranged in eachcavity 112. - What is shown is the
chip 100 after purification. Here, thecellular DNA 500 is present isolated in anaqueous phase 300 in thevarious wells 112. -
FIG. 6 shows a diagram of sequencing ofDNA 500 in asequencing device 100 according to one exemplary embodiment. In this case, thesequencing device 100 substantially corresponds to the sequencing device inFIG. 1 . Sequencing represents one step of a method for operating the sequencing device, as described inFIG. 2 . - Here, a sequencing medium 600 is introduced into the
first gap 108 and thesecond gap 110. Thepores 114 are likewise filled with the sequencing medium 600. At the same time, theaqueous solution 300 is initially arranged in thecavities 112. The aqueous solution mixes with the sequencing medium by means of diffusion. As a result, the cavities are filled with the sequencing medium (the aqueous solution is diluted out). ADC voltage source 602 is activated between theelectrical connections lid substrate 116 and thebottom substrate 118. The electric field pulls the DNA through thepores 114, and a migration rate of theDNA 500 or fragments of theDNA 500 in the sequencing medium 600 can be evaluated. - What is shown is an exemplary embodiment of a sequencing process. To this end, the
microfluidic gaps pores 114 have an electrophoresis path, for example the same buffer 600 with which thegaps - When a voltage is applied to the
lid substrate 116 and thebottom substrate 118, thecellular DNA 500 of each well 112 is conducted through thepores 114 connected to thewells 112. - The detection of the fragment length of the
DNA 500 and/or the detection of specific bases can be achieved using known methods. For example, the detection can be achieved by electrical, electrochemical or optical means. Different buffers 600 can be used depending on the detection method. For example, it is possible to use 1 M KCl salt solution containing 10 mM Tris-HCl and 1 mM EDTA (ethylenediaminetetraacetic acid), pH 8.0 at room temperature or 3 M KCl solution, pH 10.4, containing 1 mM EDTA for the electrical detection using a solid-state nanopore. - If an exemplary embodiment comprises an “and/or” link between a first feature and a second feature, this is to be read as meaning that the exemplary embodiment has, according to one embodiment, both the first feature and the second feature and, according to a further embodiment, either only the first feature or only the second feature.
Claims (20)
1. A sequencing device, comprising:
at least one sequencing channel configured to fluidically connect a first gap with a second gap, wherein:
the sequencing channel is formed as a cavity in a region of the first gap and is formed as a pore in a region of the second gap, and
the pore has a smaller cross section than the cavity.
2. The sequencing device according to claim 1 , wherein the cavity is configured to accommodate an individual cell.
3. The sequencing device according to claim 1 , wherein at least one of the first gap and the second gap has a gap width between two micrometers and two millimeters.
4. The sequencing device according to claim 1 , wherein an electrophoresis path is arranged and/or formed in the pore.
5. The sequencing device according to claim 1 , further comprising at least one further sequencing channel.
6. A method for operating a microfluidic sequencing device having at least one microfluidic sequencing channel configured to fluidically connect a first microfluidic gap with a second microfluidic gap, wherein the sequencing channel is formed as a cavity in a region of the first gap and is formed as a pore in a region of the second gap, and wherein the pore has a smaller cross section than the cavity, the method comprising:
feeding a sample solution into the first gap in order to introduce a cell into the cavity;
lysing the cell into its cellular constituents in order to release cellular DNA of the cell;
rinsing the first gap to remove undesired cellular constituents of the cell from the cavity and/or the first gap and to isolate the DNA in the cavity;
filling the first gap and the second gap with a sequencing buffer; and
sequencing the DNA in the pore.
7. The method according to claim 6 , wherein an aqueous solution containing cells is the sample solution.
8. The method according to claim 6 , wherein feeding the sample solution into the first gap further includes carrying out at least one of a centrifugation, a sedimentation, and a vacuum treatment to introduce the cell into the cavity.
9. The method according to claim 6 , wherein lysing the cell further includes carrying out at least one of a chemical lysis, an enzymatic lysis, an electrical lysis, an ultrasonic lysis, and a thermal lysis to release the cellular DNA.
10. The method according to claim 6 , wherein lysing further includes introducing an organic phase into the first gap by a laminar flow.
11. The method according to claim 6 , wherein rinsing includes introducing a rinse liquid into the first gap by a laminar flow.
12. The method according to claim 6 , wherein sequencing includes applying an electric voltage between a first substrate bounding the first gap and a second substrate bounding the second gap to sequence the DNA in the pore.
13. The method of claim 6 , wherein the method is carried out and/or controlled by a device.
14. The method according to claim 6 , wherein the method is carried out by a computer program.
15. The method according to claim 14 , wherein the computer program is stored on a machine-readable storage medium.
16. The sequencing device according to claim 2 , wherein the cavity has a cross section between five hundred nanometers and three hundred micrometers.
17. The sequencing device according to claim 16 , wherein the cavity has a cross section between one micrometer and thirty micrometers.
18. The sequencing device according to claim 3 , wherein the at least one of the first gap and the second gap has a gap width between five micrometers and 500 micrometers.
19. The sequencing device according to claim 5 , wherein the at least one further sequencing channel includes a multiplicity of sequencing channels arranged to form a matrix.
20. The sequencing device according to claim 19 , wherein the matrix has a density between 1×103 and 25×106 sequencing channels per square centimeter.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/190,308 US11186869B2 (en) | 2015-03-25 | 2018-11-14 | Sequencing device and method for operating a sequencing device |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102015205435 | 2015-03-25 | ||
DE102015205435.7A DE102015205435B4 (en) | 2015-03-25 | 2015-03-25 | Sequencing device and method for operating a sequencing device |
DE102015205435.7 | 2015-03-25 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/190,308 Division US11186869B2 (en) | 2015-03-25 | 2018-11-14 | Sequencing device and method for operating a sequencing device |
Publications (2)
Publication Number | Publication Date |
---|---|
US20160281156A1 true US20160281156A1 (en) | 2016-09-29 |
US10160999B2 US10160999B2 (en) | 2018-12-25 |
Family
ID=55919576
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/074,448 Active 2036-04-05 US10160999B2 (en) | 2015-03-25 | 2016-03-18 | Sequencing device and method for operating a sequencing device |
US16/190,308 Active 2036-06-02 US11186869B2 (en) | 2015-03-25 | 2018-11-14 | Sequencing device and method for operating a sequencing device |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/190,308 Active 2036-06-02 US11186869B2 (en) | 2015-03-25 | 2018-11-14 | Sequencing device and method for operating a sequencing device |
Country Status (5)
Country | Link |
---|---|
US (2) | US10160999B2 (en) |
EP (1) | EP3073264B1 (en) |
CN (1) | CN106010949B (en) |
DE (1) | DE102015205435B4 (en) |
ES (1) | ES2652015T3 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019060042A1 (en) * | 2017-09-22 | 2019-03-28 | Applied Materials, Inc. | Method for simple fluidic addressing of a nanopore |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115651821B (en) * | 2022-12-07 | 2023-04-07 | 北京齐碳科技有限公司 | Molecular detection unit, chip and preparation method |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040001371A1 (en) * | 2002-06-26 | 2004-01-01 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Information storage and retrieval device using macromolecules as storage media |
WO2004092403A1 (en) * | 2003-04-03 | 2004-10-28 | University Of Washington | Microwell arrays with nanoholes |
EP1877762B1 (en) * | 2005-04-06 | 2011-10-19 | President and Fellows of Harvard College | Molecular characterization with carbon nanotube control |
GB0508983D0 (en) * | 2005-05-03 | 2005-06-08 | Oxford Gene Tech Ip Ltd | Cell analyser |
US8298763B2 (en) * | 2007-03-02 | 2012-10-30 | Lawrence Livermore National Security, Llc | Automated high-throughput flow-through real-time diagnostic system |
WO2009117517A2 (en) * | 2008-03-18 | 2009-09-24 | Arizona Board Of Regents Acting For And On Behalf Of Arizona State University | Nanopore and carbon nanotube based dna sequencer |
WO2010117470A2 (en) * | 2009-04-10 | 2010-10-14 | Pacific Biosciences Of California, Inc. | Nanopore sequencing devices and methods |
US8926904B2 (en) * | 2009-05-12 | 2015-01-06 | Daniel Wai-Cheong So | Method and apparatus for the analysis and identification of molecules |
CA2764464A1 (en) * | 2009-06-05 | 2010-12-09 | Integenx Inc. | Universal sample preparation system and use in an integrated analysis system |
JP2015525077A (en) * | 2012-06-15 | 2015-09-03 | ジェニア・テクノロジーズ・インコーポレイテッド | Chip configuration and highly accurate nucleic acid sequencing |
EP2864502B1 (en) * | 2012-06-20 | 2019-10-23 | The Trustees of Columbia University in the City of New York | Nucleic acid sequencing by nanopore detection of tag molecules |
DE102012216497A1 (en) * | 2012-09-17 | 2014-03-20 | Robert Bosch Gmbh | Electronic sensor device for detecting chemical or biological species, microfluidic device with such a sensor device and method for producing the sensor device and method for producing the microfluidic device |
US9752181B2 (en) * | 2013-01-26 | 2017-09-05 | Denovo Sciences, Inc. | System and method for capturing and analyzing cells |
CN105026562B (en) * | 2013-03-12 | 2019-06-07 | 株式会社日立制作所 | Gene quantification, sequence analysis two-dimentional cellular array device and device |
US9222130B2 (en) * | 2013-03-15 | 2015-12-29 | Keith Oxenrider | Method and apparatus for sequencing molecules |
DE102013217694A1 (en) * | 2013-09-04 | 2015-03-05 | Cytocentrics Bioscience Gmbh | Apparatus and method for measurement on membranes and cells |
WO2016117541A1 (en) * | 2015-01-22 | 2016-07-28 | 株式会社村田製作所 | Void array structure and method for producing same |
-
2015
- 2015-03-25 DE DE102015205435.7A patent/DE102015205435B4/en active Active
-
2016
- 2016-03-11 EP EP16159932.9A patent/EP3073264B1/en active Active
- 2016-03-11 ES ES16159932.9T patent/ES2652015T3/en active Active
- 2016-03-18 US US15/074,448 patent/US10160999B2/en active Active
- 2016-03-24 CN CN201610171651.6A patent/CN106010949B/en active Active
-
2018
- 2018-11-14 US US16/190,308 patent/US11186869B2/en active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019060042A1 (en) * | 2017-09-22 | 2019-03-28 | Applied Materials, Inc. | Method for simple fluidic addressing of a nanopore |
Also Published As
Publication number | Publication date |
---|---|
US20190106743A1 (en) | 2019-04-11 |
US11186869B2 (en) | 2021-11-30 |
DE102015205435B4 (en) | 2023-02-16 |
EP3073264B1 (en) | 2017-09-13 |
CN106010949A (en) | 2016-10-12 |
EP3073264A1 (en) | 2016-09-28 |
CN106010949B (en) | 2021-07-23 |
DE102015205435A1 (en) | 2016-09-29 |
ES2652015T3 (en) | 2018-01-31 |
US10160999B2 (en) | 2018-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11307171B2 (en) | Nanofluidic devices for the rapid mapping of whole genomes and related systems and methods of analysis | |
US12006496B2 (en) | Isotachophoresis for purification of nucleic acids | |
CN111432919B (en) | Systems, devices, and methods for isotachophoresis | |
US10308977B2 (en) | Device and method for processing a biological sample and analysis system for analyzing a biological specimen | |
US11186869B2 (en) | Sequencing device and method for operating a sequencing device | |
US7018520B2 (en) | Concentration and cleanup of nucleic acid samples | |
JP4366523B2 (en) | Electrophoresis chip and sample analysis method using the same | |
JP2023545478A (en) | Electrophoretic devices and methods for next generation sequencing library preparation | |
US8061187B2 (en) | Lossless droplet transfer of droplet-based microfluidic analysis | |
US20190300932A1 (en) | Nano-deterministic lateral displacement array for next-generation sequencing sample preparation and high-sensitivity dna detection | |
WO2023221960A1 (en) | Microfluidic device, system, kit, method of analyzing nucleic acids, method of manipulating nucleic acids, method of detecting a biomolecule, and method of analyzing a biomolecule | |
Zhuang | Development of a Fully Integrated “Sample-In-Answer-Out” System for Automatic Genetic Analysis | |
JP2014171432A (en) | Apparatus and method for preparing nucleic acids | |
WO2024086523A2 (en) | Devices, systems, and methods for processing biological samples using isotachophoresis | |
EP4373929A1 (en) | Methods and devices for nucleic acid extraction using epitachophoresis | |
US8101057B2 (en) | Concentration and cleanup of nucleic acid samples | |
Chou et al. | Preface to Special Topic: Selected Papers from the Advances in Microfluidics and Nanofluidics 2014 Conference in Honor of Professor Hsueh-Chia Chang's 60th Birthday |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ROBERT BOSCH GMBH, GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HOFFMANN, JOCHEN;LEMUTH, KARIN;SIGNING DATES FROM 20160420 TO 20160428;REEL/FRAME:039278/0704 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 4 |